DuLac Farmaceutici, the Italian pharmaceutical company known for its recovery-focused dermo-cosmetic products and European pharmacy heritage, today announced plans to broaden its U.S. presence as consumer demand grows through its Amazon channel. The company aims to expand awareness and availability across additional retail, e-commerce, wellness, and distribution channels to meet the diverse needs of the American lifestyle.
DuLac’s U.S. presence is currently anchored by its availability on Amazon, where American consumers can discover the company’s recovery, vascular wellness, and microcirculation support food supplements. Consumer response on Amazon has validated U.S. demand for DuLac’s Italian-developed product portfolio, including the high-concentration Arnica Gel 98% and the advanced Dinaven and Diosmin lines. The company views this momentum as a foundation for broader expansion into physical retail, wholesale, and additional U.S. distribution opportunities.
Built on more than 30 years of European pharmaceutical expertise, DuLac develops wellness solutions engineered for active lifestyles. As American consumers increasingly embrace outdoor activities and long-distance travel, the demand for targeted recovery and venous support has become a year-round priority. DuLac’s portfolio addresses these seasonal shifts by combining traditional botanical knowledge with rigorous pharmaceutical standards.
“DuLac was built on the belief that consumers deserve products that combine traditional botanical knowledge with rigorous pharmaceutical standards,” said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. “As more U.S. consumers discover our products through Amazon, we see a clear opportunity to expand access across additional channels and introduce more Americans to Italian pharmacy innovation.”
The company’s growth is anchored in a unique product philosophy that unites traditional ingredients with modern formulation science. This includes the proprietary Arnica Montana Arricchita™ project, which utilizes indoor vertical farming to ensure botanical integrity, and the use of micronized Diosmin MPFF, which doubles intestinal absorption for targeted vascular support. Technological advancements such as solvent-free Supercritical CO₂ Extraction and GMP and ISO-certified manufacturing define the DuLac difference.
The implications for U.S. consumers are significant. DuLac’s expansion brings pharmacy-grade recovery and vascular wellness products to a wider audience, offering scientifically backed alternatives for muscle recovery, microcirculation support, and venous health. The company’s pharmaceutical heritage and certified quality standards, including GMP, ISO 22716, and ISO 9001, provide a level of trust and efficacy that sets DuLac apart in the crowded wellness market. For business leaders, this move underscores the growing convergence of European pharmaceutical innovation with U.S. consumer demand, opening new distribution opportunities in retail and wellness channels.
As DuLac prepares for broader U.S. expansion, the company is focused on increasing consumer awareness while building relationships across retail, wholesale, e-commerce, and wellness-focused distribution channels. Consumers can currently explore DuLac Farmaceutici products through the company’s Amazon U.S. storefront.
